Italian biotech AAVantgarde adds $141M series B to fund retinal disease gene therapy trials November 3, 2025
James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise September 30, 2025
Avenzo collects another $60M for two small molecules and two ADCs licensed from China September 22, 2025
